Class II · Moderate riskTerminated Initiated May 2, 2013 (13 years ago)
Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
What was recalled
Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL
Recalling firm
The Compounding Shop, INC.
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-548-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.